$NANX
NANOPHASE TECHNOLOGIES Corp

2016 Q1 Form 10-K Financial Statement

#000119312516520642 Filed on March 29, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015
Revenue $2.211M $2.280M $10.31M
YoY Change -4.29% 25.27% 3.79%
Cost Of Revenue $1.755M $1.610M $7.199M
YoY Change 0.57% 5.92% 1.32%
Gross Profit $456.0K $670.0K $3.114M
YoY Change -19.29% 123.33% 10.0%
Gross Profit Margin 20.62% 29.39% 30.19%
Selling, General & Admin $761.0K $700.0K $3.019M
YoY Change -12.12% -14.63% -6.1%
% of Gross Profit 166.89% 104.48% 96.95%
Research & Development $301.0K $300.0K $1.273M
YoY Change -0.33% -14.29% -4.86%
% of Gross Profit 66.01% 44.78% 40.88%
Depreciation & Amortization $182.0K $190.0K $735.0K
YoY Change -1.09% 5.56% -0.94%
% of Gross Profit 39.91% 28.36% 23.6%
Operating Expenses $1.062M $1.000M $4.292M
YoY Change -9.08% -15.25% -5.73%
Operating Profit -$606.0K -$330.0K -$1.178M
YoY Change 0.5% -62.5% -31.59%
Interest Expense $4.000K -$10.00K $14.00K
YoY Change 33.33% 133.33%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$610.0K -$340.0K -$1.192M
YoY Change 0.66% -61.36% -30.98%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$610.0K -$340.0K -$1.192M
YoY Change 0.66% -61.36% -30.98%
Net Earnings / Revenue -27.59% -14.91% -11.56%
Basic Earnings Per Share
Diluted Earnings Per Share -$20.33K -$11.89K -$41.71K
COMMON SHARES
Basic Shares Outstanding 31.19M shares 28.59M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.480M $1.280M $1.275M
YoY Change 22.31% -31.18% -31.53%
Cash & Equivalents $1.478M $1.275M $1.275M
Short-Term Investments
Other Short-Term Assets $300.0K $250.0K $247.0K
YoY Change -14.29% -32.43% -32.7%
Inventory $758.0K $662.0K $662.0K
Prepaid Expenses
Receivables $929.0K $507.0K $507.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.462M $2.691M $2.691M
YoY Change -5.02% -24.56% -24.56%
LONG-TERM ASSETS
Property, Plant & Equipment $1.742M $1.861M $1.861M
YoY Change -12.59% -12.96% -12.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $22.00K $22.00K $22.00K
YoY Change -8.33% -12.0% -12.0%
Total Long-Term Assets $1.764M $1.883M $1.883M
YoY Change -12.54% -12.94% -12.94%
TOTAL ASSETS
Total Short-Term Assets $3.462M $2.691M $2.691M
Total Long-Term Assets $1.764M $1.883M $1.883M
Total Assets $5.226M $4.574M $4.574M
YoY Change -7.7% -20.17% -20.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $715.0K $508.0K $508.0K
YoY Change -29.14% 3.04% 3.04%
Accrued Expenses $331.0K $276.0K $276.0K
YoY Change -18.87% -33.17% -33.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $90.00K $94.00K
YoY Change 66.67% 28.57% 34.29%
Total Short-Term Liabilities $1.142M $878.0K $878.0K
YoY Change -22.79% -10.04% -10.04%
LONG-TERM LIABILITIES
Long-Term Debt $120.0K $140.0K $144.0K
YoY Change 9.09% 16.67% 19.01%
Other Long-Term Liabilities $680.0K $690.0K $691.0K
YoY Change -10.53% -12.66% -12.2%
Total Long-Term Liabilities $799.0K $835.0K $835.0K
YoY Change -8.16% -8.04% -8.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.142M $878.0K $878.0K
Total Long-Term Liabilities $799.0K $835.0K $835.0K
Total Liabilities $1.941M $1.713M $1.713M
YoY Change -17.37% -9.08% -9.08%
SHAREHOLDERS EQUITY
Retained Earnings -$94.21M -$93.60M
YoY Change 1.29% 1.29%
Common Stock $312.0K $286.0K
YoY Change 9.09% 0.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.285M $2.861M $2.861M
YoY Change
Total Liabilities & Shareholders Equity $5.226M $4.574M $4.574M
YoY Change -7.7% -20.17% -20.17%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$610.0K -$340.0K -$1.192M
YoY Change 0.66% -61.36% -30.98%
Depreciation, Depletion And Amortization $182.0K $190.0K $735.0K
YoY Change -1.09% 5.56% -0.94%
Cash From Operating Activities -$700.0K $300.0K -$240.0K
YoY Change 14.75% -203.45% -79.68%
INVESTING ACTIVITIES
Capital Expenditures $27.00K -$50.00K $280.0K
YoY Change -28.95% -138.46% 29.63%
Acquisitions
YoY Change
Other Investing Activities -$40.00K $0.00 -$8.000K
YoY Change 300.0% -366.67%
Cash From Investing Activities -$60.00K -$50.00K -$288.0K
YoY Change 20.0% -135.71% 20.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $988.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 970.0K -230.0K -59.00K
YoY Change -1083.33%
NET CHANGE
Cash From Operating Activities -700.0K 300.0K -240.0K
Cash From Investing Activities -60.00K -50.00K -288.0K
Cash From Financing Activities 970.0K -230.0K -59.00K
Net Change In Cash 210.0K 20.00K -587.0K
YoY Change -131.82% -113.33% -58.49%
FREE CASH FLOW
Cash From Operating Activities -$700.0K $300.0K -$240.0K
Capital Expenditures $27.00K -$50.00K $280.0K
Free Cash Flow -$727.0K $350.0K -$520.0K
YoY Change 12.19% -183.33% -62.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31185496 shares
CY2015Q2 dei Entity Public Float
EntityPublicFloat
7025000
CY2013Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
160000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
5368000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3276000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2440000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.15
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28516163 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24088 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28516163 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
52000
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
908000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
154000
CY2014Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
166000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
259000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
3846000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95966000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
621000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
493000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
413000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92405000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5730000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
285000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17663000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
976000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33555000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
29000
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
70000
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
121000
CY2014Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2014Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6000
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
173000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31252000
CY2015Q4 us-gaap Assets
Assets
4574000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
225000
CY2015Q4 us-gaap Inventory Net
InventoryNet
662000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
507000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1861000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q4 us-gaap Assets Current
AssetsCurrent
2691000
CY2015Q4 us-gaap Inventory Gross
InventoryGross
714000
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
81000000
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
530000
CY2015Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
316000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
247000
CY2015Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
21000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1275000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20250000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41000
CY2015Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
67000
CY2015Q4 nanx Operating Loss And Tax Credit Carry Forward Valuation Allowance
OperatingLossAndTaxCreditCarryForwardValuationAllowance
0
CY2015Q4 nanx Common Stock Closing Price
CommonStockClosingPrice
0.40
CY2015Q4 nanx Capital Leases Future Minimum Payments Due Principal
CapitalLeasesFutureMinimumPaymentsDuePrincipal
238000
CY2015Q4 nanx Financial Assets Liabilities Fair Value Disclosure
FinancialAssetsLiabilitiesFairValueDisclosure
0
CY2014Q4 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
184000
CY2014Q4 nanx Lessee Leasing Arrangements Capital Leases Term Of Contract
LesseeLeasingArrangementsCapitalLeasesTermOfContract
P3Y
CY2014Q4 nanx Number Of Capital Leases
NumberOfCapitalLeases
1 Lease
CY2011 nanx Extension Of Term Of Net Loss Carryforwards
ExtensionOfTermOfNetLossCarryforwards
P4Y
CY2011 nanx Period For Suspension Of Net Operating Loss Carryforwards
PeriodForSuspensionOfNetOperatingLossCarryforwards
P4Y
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1181000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020 pure
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.42
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.95
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28585496 shares
CY2014Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
29000
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
601000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
33555000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1326000
CY2014Q4 us-gaap Assets
Assets
5730000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
279000
CY2014Q4 us-gaap Inventory Net
InventoryNet
950000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
388000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2138000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2014Q4 us-gaap Assets Current
AssetsCurrent
3567000
CY2014Q4 us-gaap Inventory Gross
InventoryGross
1002000
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
829000
CY2014Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
272000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
367000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1862000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19801000
CY2014Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
62000
CY2014Q4 nanx Operating Loss And Tax Credit Carry Forward Valuation Allowance
OperatingLossAndTaxCreditCarryForwardValuationAllowance
0
CY2014Q4 nanx Capital Loss Carryforwards
CapitalLossCarryforwards
300000
CY2014Q4 nanx Financial Assets Liabilities Fair Value Disclosure
FinancialAssetsLiabilitiesFairValueDisclosure
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2574000 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1656000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24088 shares
CY2015Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
445000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28585496 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.21
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
556000
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
52000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
645000
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
835000
CY2015Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
168000
CY2015Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
172000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4243000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
108000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
2861000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
413000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96172000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
519000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
508000
CY2015Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
100000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
276000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93597000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4574000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
286000
CY2015Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
11000
CY2015Q4 us-gaap Investment Related Liabilities
InvestmentRelatedLiabilities
0
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
105000
CY2015Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
16000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
444000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18389000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1752000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
878000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
34021000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
433000
CY2015Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
29000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
94000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
144000
CY2015Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
259000
CY2015Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
27000
CY2015Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2015Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6000
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
184000
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
41000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31590000
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
28000
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
709000
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
204000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
34021000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1396000
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
35000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.95 pure
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28482256 shares
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
34000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
216000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-1727000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
9936000
CY2014 us-gaap Interest Paid
InterestPaid
6000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
167000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-1722000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-26000
CY2014 us-gaap Interest Income Other
InterestIncomeOther
1000
CY2014 us-gaap Gross Profit
GrossProfit
2831000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
700000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
336000
CY2014 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1000
CY2014 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
23000
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
195000
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9880000
CY2014 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
0
CY2014 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8000
CY2014 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
56000
CY2014 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
184000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1727000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
188000
CY2014 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6000
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
658000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1414000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
669000
CY2014 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
30000
CY2014 us-gaap Interest Expense
InterestExpense
6000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-239000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1338000
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
87000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
195000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-587000
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3215000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5000
CY2014 us-gaap Depreciation
Depreciation
734000
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
742000
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
7105000
CY2014 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
0
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-88000
CY2014 nanx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.04 pure
CY2014 nanx Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
0
CY2014 nanx Capital Loss Carryforwards Expiration Year
CapitalLossCarryforwardsExpirationYear
2014
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Nature Of Operations
NatureOfOperations
<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><b>(1)</b></td> <td valign="top" align="left"><b>Description of Business</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"> Nanophase Technologies Corporation (&#x201C;Nanophase&#x201D;, &#x201C;Company&#x201D;, &#x201C;we&#x201D;, &#x201C;our&#x201D;, or &#x201C;us&#x201D;) is an advanced materials and applications developer and commercial manufacturer with an integrated family of nanomaterial and related technologies. We produce engineered nano and larger, sub-micron, materials for use in a variety of diverse markets: personal care including sunscreens, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy, and a variety of surface finishing technologies (polishing) applications. We target markets in which we believe practical solutions may be found using our products. We work closely with current and potential customers in these target markets to identify their material and performance requirements and market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products possible and opened potential new markets. We recently developed new material solutions in the surface finishing technologies (polishing) and energy-management areas that have been taken to potential customers, and for which we are experiencing early-stage, accelerating revenue growth. We also developed a new coating which we used to launch new products in personal care, beginning in 2015. Although our primary strategic focus has been the North American market, we currently sell material to customers overseas and have been working to expand our reach within foreign markets. The Company was incorporated in Illinois on November&#xA0;25, 1989, and became a Delaware corporation during November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"> While product sales comprise the majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected to drive the long-term growth of the business. For this reason, we classify such revenue as &#x201C;other revenue&#x201D; in our Statements of Operations, as it does not represent revenue directly from our nanocrystalline materials.</p> </div>
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-240000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2015 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 BusinessSegments
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017 pure
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0000883107
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-3000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
588000
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.44
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Registrant Name
EntityRegistrantName
NANOPHASE TECHNOLOGIES CORPORATION
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
461000 shares
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 us-gaap Revenue Recognition Software
RevenueRecognitionSoftware
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Other Revenue</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 8%"> Other revenue may include revenue from technology license fees and paid development projects. Technology license fees and paid development projects are recognized when earned pursuant to the agreed upon contractual arrangement, when performance obligations are satisfied, the amount is fixed or determinable, and collectability is reasonably assured.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 8%"> Shipping and handling costs are included in other revenue when products are shipped and invoiced to the customer. We include the related cost of shipping and handling in cost of goods sold.</p> </div>
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
258000 shares
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.37
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.36
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>Use of Estimates and Risks and Uncertainties</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px"> The preparation of financial statements requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Certain assumptions are also necessary to assess the impact of risks and uncertainties on the financial statements, such as cash flow projections, availability of capital if needed to support the ongoing operations of the business, and our expected compliance with contractual commitments. These risks and uncertainties are further discussed in Note 12. Any changes in these assumptions or business plans could have a material impact on the financial statements.</p> </div>
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
69000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.95 pure
CY2015 dei Trading Symbol
TradingSymbol
NANX
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28574902 shares
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1192000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
182000
CY2015 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.20
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
85000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
280000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-1192000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
10313000
CY2015 us-gaap Interest Paid
InterestPaid
14000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-120000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-1178000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-288000
CY2015 us-gaap Gross Profit
GrossProfit
3114000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
500000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
119000
CY2015 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8000
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
181000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10272000
CY2015 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
132000
CY2015 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
0
CY2015 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
37000
CY2015 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
41000
CY2015 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
132000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-587000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
466000
CY2015 us-gaap Interest Expense
InterestExpense
14000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-288000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-59000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1273000
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-240000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
181000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-405000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3019000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14000
CY2015 us-gaap Depreciation
Depreciation
726000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
735000
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
7199000
CY2015 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
0
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-61000
CY2015 nanx Defined Contribution Plan Employer Matching Contribution Percent For First Compensation Slab
DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab
0.03 pure
CY2015 nanx Operating Loss Carryforwards Expiration Year End
OperatingLossCarryforwardsExpirationYearEnd
2035
CY2015 nanx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.04 pure
CY2015 nanx Income Tax Recognition Threshold Percentage
IncomeTaxRecognitionThresholdPercentage
0.50 pure
CY2015 nanx Cash And Cash Equivalents Maturity Period Description
CashAndCashEquivalentsMaturityPeriodDescription
90 days or less
CY2015 nanx Defined Contribution Plan Employer Matching Contribution Percent For Next Compensation Slab
DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab
0.02 pure
CY2015 nanx Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
0
CY2015 nanx Number Of Capital Leases
NumberOfCapitalLeases
3 Lease
CY2015 nanx Major Customers Number Of Customers
MajorCustomersNumberOfCustomers
3 Customer
CY2015 nanx Operating Loss Carryforwards Expiration Year Start
OperatingLossCarryforwardsExpirationYearStart
2018
CY2015 nanx Defined Contribution Plan Employer Matching Contribution Percent For Three Percent Of Employee Contribution
DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution
1.00 pure
CY2015 nanx Defined Contribution Plan Employer Matching Contribution Percent For Two Percent Of Employee Contribution
DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution
0.50 pure
CY2015 nanx Accounts Receivables Credit Period
AccountsReceivablesCreditPeriod
P30D

Files In Submission

Name View Source Status
0001193125-16-520642-index-headers.html Edgar Link pending
0001193125-16-520642-index.html Edgar Link pending
0001193125-16-520642.txt Edgar Link pending
0001193125-16-520642-xbrl.zip Edgar Link pending
d256013d10k.htm Edgar Link pending
d256013dex231.htm Edgar Link pending
d256013dex311.htm Edgar Link pending
d256013dex312.htm Edgar Link pending
d256013dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nanx-20151231.xml Edgar Link completed
nanx-20151231.xsd Edgar Link pending
nanx-20151231_cal.xml Edgar Link unprocessable
nanx-20151231_def.xml Edgar Link unprocessable
nanx-20151231_lab.xml Edgar Link unprocessable
nanx-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending